Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sjögren's syndrome. Controversies and progress

R I Fox1

  • 1Division of Rheumatology, Scripps Clinic and Research Foundation, La Jolla, California, USA.

Clinics in Laboratory Medicine
|October 8, 1997
PubMed
Summary

Diagnostic criteria for Sjögren's syndrome (SS) are debated, impacting patient care and research. Understanding the autoimmune basis versus symptom complex is crucial for accurate diagnosis and treatment of this systemic disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The incidence of pulmonary hypertension is higher in systemic lupus and Sjögren's patients than in scleroderma patients in China.

Lupus·2018
Same author

How does leflunomide modulate the immune response in rheumatoid arthritis?

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
Same author

Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone.

Rheumatology (Oxford, England)·2003
Same author

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Annals of the rheumatic diseases·2002
Same author

The value of noninvasive studies of parotid glands in primary Sjögren's syndrome.

Arthritis and rheumatism·2002
Same author

Use of muscarinic agonists in the treatment of Sjögren's syndrome.

Clinical immunology (Orlando, Fla.)·2001

Area of Science:

  • Immunology
  • Rheumatology
  • Pathogenesis of Autoimmune Diseases

Background:

  • Diagnostic criteria for Sjögren's syndrome (SS) are essential for clinical management, research, and insurance purposes.
  • Current criteria are debated, causing confusion in distinguishing SS from other conditions causing dry eyes and mouth.
  • Primary SS is a systemic autoimmune disease affecting lacrimal and salivary glands.

Purpose of the Study:

  • To address the controversy surrounding the definition of Sjögren's syndrome (SS).
  • To differentiate between SS as a restricted autoimmune exocrinopathy versus a broader symptom complex.
  • To highlight the importance of distinguishing SS from other causes of sicca symptoms.

Main Methods:

  • Review of existing diagnostic criteria and literature on Sjögren's syndrome.
  • Examination of recent research on the pathogenesis of SS in human and animal models.
  • Comparison of lymphocyte behavior in blood versus glandular tissue in SS patients.

Main Results:

  • The definition of SS remains controversial, impacting clinical and research consistency.
  • Pathogenesis studies explore T-cell clonality, cytokine production, and neuroendocrine factors.
  • Glandular microenvironment differences influence autoimmune processes, with some T cells showing resistance to apoptosis.

Conclusions:

  • Accurate diagnostic criteria are vital for consistent patient care and research into Sjögren's syndrome.
  • Understanding the specific autoimmune mechanisms is key to differentiating SS from other sicca-inducing conditions.
  • Ongoing research into pathogenesis, including apoptosis regulation, is improving the understanding of SS manifestations.

Related Experiment Videos